首页 | 本学科首页   官方微博 | 高级检索  
检索        

NIP方案治疗晚期乳腺癌的临床观察
引用本文:张国平,赖淑贞,刘丹婵.NIP方案治疗晚期乳腺癌的临床观察[J].现代肿瘤医学,2004,12(3):207-208.
作者姓名:张国平  赖淑贞  刘丹婵
作者单位:广东省韶关粤北人民医院肿瘤内科,广东韶关 512026
摘    要:目的 观察长春瑞滨(NVB)、异环磷酰胺(IFO)和顺铂(DDP)方案治疗转移性乳腺癌的临床疗效和毒性。方法 46例晚期乳腺癌采用NVB25mg/m^2,d1、d8;异环磷酰胺(IFO)2.0dl~d5,Mesna400mg静滴,3次/13(每4小时一次);DDP20mg/m^2,d1~d5;每28天一个周期,完成2个周期后评价疗效。结果 总有效率(CR PR)63.04%,CR0例,PR29例。最常见的毒副反应为血液毒性及胃肠道反应。结论 NIP方案治疗转移性乳腺癌疗效较高,毒副作用可耐受。

关 键 词:乳腺癌  长春瑞滨  异环磷酰胺  顺铂  联合化疗
文章编号:1672-4992(2004)03-207-02
修稿时间:2003年12月29

Treatment of advanced breast cancer with the regimen of Vinorebine,Ifosfimide and Cisplatin
ZHANG Guo-ping,LAI Shu-zhen,LIU Dan-chan.Treatment of advanced breast cancer with the regimen of Vinorebine,Ifosfimide and Cisplatin[J].Journal of Modern Oncology,2004,12(3):207-208.
Authors:ZHANG Guo-ping  LAI Shu-zhen  LIU Dan-chan
Institution:ZHANG Guo-ping,LAI Shu-zhen,LIU Dan-chan Department of medical oncology,Yuebei People's Hospital,Guangdong Shaoguan 512026,China.
Abstract:Objective To observe the curative effects and side effects of NIP regimen(NVB,IFO and DDP)in metastatic breast cancer.Methods 46 patients with advanced breast cancer were treated by NIP regimen.NVB 25mg/m2 iv on day 1 and 8;IFO 2.0 iv on days 1 to 5,and Mesna 400mg iv at hours 0,4,8 on day 1;DDP 20mg iv on days 1 to 5.Every 28 days were as one cycle.Assessment was given after 2 cycles.Results The overall response rate(CR+PR)was 63.04%.The major side effects were myelosuppression,nausea and vomiting.Conclusion The study shows that the regimen of NIP is effective and tolerable fro treatment of advanced breast cancer.
Keywords:breast tumor  vinorebine  ifosfimide  cisplatin  combination chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号